Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer
48-Hour Crisis Action Plan Hours 1-4: Immediate Assessment & Team Assembly 1:00 AM - 3:00 AM: Contact my most trusted external crisis counsel (not our usual firm - potential conflicts) Summon head of R&D, Chief Medical Officer, and Head of Regulatory Affairs immediately Secure all internal research documents and…Read the full answer